ST Germain D J Co. Inc. Sells 44,669 Shares of CVS Health Co. (NYSE:CVS)

ST Germain D J Co. Inc. cut its holdings in shares of CVS Health Co. (NYSE:CVS - Free Report) by 15.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 248,613 shares of the pharmacy operator's stock after selling 44,669 shares during the period. ST Germain D J Co. Inc.'s holdings in CVS Health were worth $11,160,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Assetmark Inc. grew its stake in shares of CVS Health by 9.7% in the third quarter. Assetmark Inc. now owns 410,001 shares of the pharmacy operator's stock worth $25,781,000 after purchasing an additional 36,132 shares during the last quarter. TD Private Client Wealth LLC grew its position in shares of CVS Health by 28.7% in the 3rd quarter. TD Private Client Wealth LLC now owns 46,938 shares of the pharmacy operator's stock valued at $2,951,000 after buying an additional 10,465 shares during the last quarter. Cullinan Associates Inc. increased its stake in shares of CVS Health by 43.8% in the third quarter. Cullinan Associates Inc. now owns 122,682 shares of the pharmacy operator's stock valued at $7,125,000 after buying an additional 37,395 shares during the period. Principal Financial Group Inc. lifted its stake in shares of CVS Health by 4.8% in the third quarter. Principal Financial Group Inc. now owns 1,434,476 shares of the pharmacy operator's stock worth $90,200,000 after acquiring an additional 66,244 shares during the period. Finally, Sompo Asset Management Co. Ltd. boosted its holdings in CVS Health by 8.4% in the third quarter. Sompo Asset Management Co. Ltd. now owns 134,523 shares of the pharmacy operator's stock valued at $8,459,000 after acquiring an additional 10,453 shares during the last quarter. 80.66% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the stock. StockNews.com lowered shares of CVS Health from a "hold" rating to a "sell" rating in a report on Thursday, November 14th. Royal Bank of Canada dropped their target price on shares of CVS Health from $68.00 to $58.00 and set an "outperform" rating on the stock in a report on Friday, November 15th. UBS Group increased their price target on CVS Health from $60.00 to $62.00 and gave the stock a "neutral" rating in a report on Thursday, November 7th. Wells Fargo & Company raised CVS Health from an "equal weight" rating to an "overweight" rating and boosted their price objective for the company from $60.00 to $66.00 in a research note on Monday, November 18th. Finally, Truist Financial decreased their target price on CVS Health from $67.00 to $60.00 and set a "buy" rating for the company in a research note on Monday. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $68.71.

CVS Health Stock Up 4.3 %

Shares of NYSE:CVS traded up $1.99 during midday trading on Friday, hitting $48.00. 16,806,787 shares of the company's stock were exchanged, compared to its average volume of 13,434,279. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $80.75. The company has a market cap of $60.40 billion, a PE ratio of 12.18, a price-to-earnings-growth ratio of 0.85 and a beta of 0.59. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The stock has a 50 day moving average price of $51.82 and a 200-day moving average price of $56.62.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The firm had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. During the same period in the prior year, the business posted $2.21 earnings per share. The company's quarterly revenue was up 6.3% compared to the same quarter last year. On average, sell-side analysts anticipate that CVS Health Co. will post 5.32 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be issued a $0.665 dividend. The ex-dividend date is Thursday, January 23rd. This represents a $2.66 annualized dividend and a dividend yield of 5.54%. CVS Health's dividend payout ratio is currently 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.